Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) has received an average rating of “Moderate Buy” from the seventeen analysts that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $43.06.
Several research analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Telsey Advisory Group reissued an “outperform” rating and issued a $42.00 target price on shares of Bath & Body Works in a research note on Monday, November 25th. Barclays raised their target price on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a report on Tuesday, November 26th. Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $42.00 to $48.00 in a research report on Friday. Finally, Argus reissued a “hold” rating on shares of Bath & Body Works in a research note on Friday.
Read Our Latest Stock Analysis on Bath & Body Works
Institutional Trading of Bath & Body Works
Bath & Body Works Price Performance
Bath & Body Works stock opened at $36.45 on Monday. The firm has a market cap of $7.89 billion, a price-to-earnings ratio of 8.89, a P/E/G ratio of 1.43 and a beta of 1.82. The firm has a fifty day moving average price of $35.75 and a two-hundred day moving average price of $33.68. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99.
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same period in the prior year, the company posted $0.48 earnings per share. Bath & Body Works’s revenue was up 3.1% on a year-over-year basis. As a group, sell-side analysts expect that Bath & Body Works will post 3.26 earnings per share for the current year.
Bath & Body Works Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.19%. The ex-dividend date of this dividend was Friday, November 22nd. Bath & Body Works’s payout ratio is 19.51%.
Bath & Body Works Company Profile
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- What Are Dividend Contenders? Investing in Dividend Contenders
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- What is the FTSE 100 index?
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.